Vimarsana
Biggest News Aggregation in the World

Page 6 - Cancer Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cancer Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cancer Development Today - Breaking & Trending Today

New Study Reveals Smoking-Induced DNA Mutations Fuel Cancer Risk - Vimarsana News

New Study Reveals Smoking-Induced DNA Mutations Fuel Cancer Risk

Research conducted over time has consistently demonstrated that smoking has the potential to induce harmful alterations in DNA.

Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer - Vimarsana News

Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

Seagen Inc. today announced that the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA® in combination with the antibody-drug conjugate ado-trastuzumab emtansine met its primary endpoint of... -Today at 08:06 am- MarketScreener

Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzu - Vimarsana News

Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzu

BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA® (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla®) met its primary endpoint of progression-free survival (PFS). Patients in the trial had u...

A new vision for ultrasound imaging - Vimarsana News

A new vision for ultrasound imaging

Nicole Henning, a research specialist at the Preclinical Imaging and Testing Core Facility at MIT's Koch Institute, has advanced medical research with her invention of USGI, an ultrasound imaging system for studying disease development.

Source: mit.edu
There's a Much Bigger Danger to Your Health Than Aspartame in Your Soda - Vimarsana News

There's a Much Bigger Danger to Your Health Than Aspartame in Your Soda

UnsplashSorry, Diet Coke addicts. The World Health Organization (WHO) designated aspartame, an artificial sweetener commonly used in diet sodas, as “possibly carcinogenic to humans” on Thursday—despite a conflicting assertion from the U.S. Food and Drug Administration.The decision comes from a panel of 25 researchers and experts at the WHO’s International Agency for Research on Cancer (IARC) who published their decision in The Lancet Oncology. The committee wrote that the classification was a re

Source: yahoo.com